HTFL Options (HTFL20260417C22.5) Price & Quote

Symbols

--(--)

Expected P&L on Expiry

Key Stats

0.00DAY`S RANGE0.00

Open

0.00

Prev.Close

0.00

Turnover

Volume

Premium

Extrinsic Value

Open Interest

Intrinsic Value

Pricing Model

Delta

Gamma

Theta

Vega

Rho

Theor Price

About HTFL20260417C22.5

Underlying

Heartflow, Inc.

Industry

Healthcare Equipment and Supplies

Introduction

Heartflow, Inc., was incorporated in 2007 under the laws of the State of Delaware. Heartflow, Inc., pioneered the use of software and artificial intelligence to provide a more accurate and clinically effective non-invasive solution for diagnosing and managing coronary artery disease, the leading cause of death worldwide. Their new platform utilizes artificial intelligence and advanced computational fluid dynamics to create a personalized 3-D model of a patient's heart through a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. Their Heartflow platform provides actionable insights on blood flow, stenosis, plaque volume, and plaque composition, overcoming the limitations of traditional non-invasive imaging tests that rely on indirect measurements of coronary heart disease and lead to higher false-negative and false-positive rates, as demonstrated by their precision trials.